Jove
Visualize
Contact Us

Related Experiment Videos

Radiation therapy.

Branislav Jeremic1

  • 1Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D-81675 Munich, Germany. bjeremic@lrz.tu-muenchen.de

Hematology/Oncology Clinics of North America
|March 10, 2004
PubMed
Summary

Radiation therapy (RT) is crucial for non-small cell lung cancer (NSCLC), offering cures, life extension, and symptom relief. Further translational research is needed to optimize RT and chemotherapy combinations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome.

Precision radiation oncology·2025
Same author

Trends in the treatment of human papillomavirus-associated oropharyngeal carcinoma in Slovakia.

Neoplasma·2024
Same author

Human Papillomavirus-Related Non-Metastatic Oropharyngeal Carcinoma: Current Local Treatment Options and Future Perspectives.

Cancers·2022
Same author

Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer-How to Identify Patients Which Can Benefit from It?

Current oncology (Toronto, Ont.)·2022
Same author

Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia.

Health services insights·2021
Same author

Molecular profiling and characteristics of non-small-cell lung cancer patients in Georgia.

Future oncology (London, England)·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • Radiation therapy (RT) is a cornerstone treatment for locally advanced and metastatic non-small cell lung cancer (NSCLC).
  • RT offers potential cures, prolonged survival, and symptom palliation, making it a unique therapeutic modality.
  • Despite technological advancements, optimizing RT requires understanding patient and tumor factors influencing outcomes and improving RT-chemotherapy (CHT) integration.

Purpose of the Study:

  • To highlight the indispensable role of RT in NSCLC treatment.
  • To emphasize the need for enhanced translational research in radiation oncology, particularly concerning RT-CHT interactions.
  • To identify key research areas for optimizing RT efficacy and patient outcomes.

Main Methods:

  • Review of current RT applications and challenges in NSCLC.
  • Discussion of the need for translational research bridging laboratory findings and clinical practice.
  • Identification of research priorities including imaging RT/CHT interactions, developing radiation modifiers, and understanding tumor microenvironment factors like hypoxia.

Main Results:

  • RT is a versatile and cost-effective treatment for NSCLC, improving patient quality of life.
  • Significant gaps exist in understanding RT-CHT interactions and optimizing treatment strategies.
  • Translational research is essential for advancing RT, focusing on tumor biology, microenvironment, and predictive biomarkers.

Conclusions:

  • RT remains a vital component of NSCLC management, with ongoing efforts to refine its application.
  • Future advancements in RT will likely stem from integrating technological innovation with a deeper understanding of tumor biology and patient-specific factors.
  • Continued translational research is critical for improving outcomes in NSCLC patients treated with RT and chemotherapy.

Related Experiment Videos